DIAGNOS Announces Cross-listing of its Common Shares on the Frankfurt Stock Exchange
BROSSARD, Quebec, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A) a pioneer in early detection of critical health issues through the use of its FLAIRE platform based on Artificial …